retatrutide triple agonist glp-1 gip glucagon phase 2 nejm 2023 💉 A triple-action once-weekly injection can significantly lower blood sugar and body weight in people with type diabetes, a new 3 trial shows. is part of an emerging generation Retatrutide (LY3437943): Mechanism of Action

So GLP-1 therapy reduces insulin secretion and levels, which have implications for the understanding of the mechanisms behind its effect on weight loss

Glucagon is also involved in glucose and lipid homeostasis, as well as in the regulation of energy expenditure and food intake [17]

A New Wave in the Pharmaceutical Sector: With growing interest and reliance on GLP-1 drugs, the pharmaceutical sector could see an impetus in the research and development of not only newer GLP-1 agonists but also other drugs that can impact both glucose regulation and weight management

M., Chen, Y., ONeill, E

Regarding the chronic effects of MCT oil, long-term MCT consumption did not induce GIP hypersecretion, and suppressed fat mass and body weight gain compared to an LCT diet [59]

This can improve insulin sensitivity and metabolic health, which can make pregnancy more likely over time